Área Cardiovascular

Grupo de Estudio de Riesgo Cardiometabólico y Renal

Josep Redón i Mas

El Dr. Redón cursa sus estudios en la Facultad de Medicina de la Universitat de València (1974), doctorándose en esta Universidad en 1985. Desde 2006 es Catedrático de Medicina Interna de Facultad de Medicina de la Universitat de València y Jefe de Servicio de Medicina Interna del Hospital Clínico de Valencia desde 1995.

Su actividad investigadora se ha realizado en paralelo a su actividad clínica poniendo en práctica una investigación traslacional en el campo de la Hipertensión Arterial y Riesgo Cardiovascular. Investigador principal y participante en un gran número de Proyectos nacionales e internacionales, actualmente es el Director Científico del Instituto de Investigación Biomédica INCLIVA. Ha cursado un Fellowship in Hypertension en el Departamento de Nefrología e Hipertensión de la NorthwesternUniversity (Prof. D Batlle) en Chicago y cuenta con estancias en el Departamento de Epidemiología y Medicina Preventiva de la Loyola University.

Está muy involucrado con las principales Sociedades Científicas de Hipertensión nacionales e internacionales. Ha sido Presidente de la Sociedad Española de Hipertensión, Presidente y Officer at Large de la European Society of Hipertensión y Fellow del Council for High Blood Pressure, American Heart Association. Miembro de Honor de las Sociedades de Hipertensión de Portugal, Bulgaria, Rumanía, España y de la Sociedad Latino-Americana (LASH). Entre otros méritos, destaca su participación como evaluador de la  Agencia Nacional de Evaluación y Prospectiva (ANECA) de la Secretaría de Estado de Universidades.

Dentro de la actividad Editorial es Miembro del Editorial Board de revistas indexadas en el campo de hipertensión, editor asociado del Journal of Hypertension, revisor de revistas del campo cardiovascular y de Medicina Interna y autor de numerosas editoriales y artículos de revisión por invitación. Cuenta con 302 publicaciones en revistas Indexadas, un total de 13.384 citas y un factor de impacto acumulado superior a 1.100.

Recientemente ha sido galardonado con el título de Doctor Honoris Causa por la Universidad Carol Davila, Bucarest, y ha recibido el Premio a la Excelencia Sanitaria del Instituto Europeo de Salud y Bienestar Social. 

 

Grupo de Estudio de Riesgo Cardiometabólico y Renal

Investigador predoctoral

Carlos Sánchez Sánchez
Javier Pérez Hernández
Oscar Calaforra Juan

Investigador

Adrian Ruiz
Gernot Helmut Pichler*
Jose Luis Holgado Sánchez

Investigadora colaboradora

María José Fabiá Valls
Elena Solaz Moreno
Mª José García-Fuster González-Alegre
Mª Jose Galindo Puerto
Mª José Forner Giner
  • Se ha finalizado el estudio de la tercera fase de daño renal, microalbuminuria y riesgo cardiovascular.
  • Completada la primera fase de análisis de combinación genómica-metabolómica.
  • Estudios de lesión endotelial en pacientes con ETV.
  • ETV y genética en fase de análisis.
  • Puesta en marcha de los estudios de podocitos en orina.
  • Metales y riesgo CV se esta en fase de análisis.
Número total de publicaciones: 200. Factor de Impacto acumulado: 1312.83
Executive summary of the consensus document on osteoporosis in HIV-infected individuals.
Negredo E, Domingo P, Gutiérrez F, Galindo MJ, Knobel H, Lozano F, Martínez E, Masiá M, Polo R, Estrada V.
Enfermedades infecciosas y microbiología clínica.. 2018 May. 312-314. FI: 1.714
Interferon-free therapy for treating HCV in difficult-to-treat HIV-coinfected patients as implemented in routine medical practice
Mínguez C, García-Deltoro M, Flores J, Galindo MJ, Montero M, Reus S, Carmena J, Masiá M, Amador C, Ortega E; On the behalf of the COINFECOVA-2 study group.
AIDS. 2018 Jan 28. 337-346. FI: 5.019
Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide at 48 weeks in adults with virologically suppr
Orkin C, Molina JM, Negredo E, Arribas JR, Gathe J, Eron JJ, Van Landuyt E, Lathouwers E, Hufkens V, Petrovic R, Vanveggel S, Opsomer M; EMERALD study group.
The lancet. HIV. 2018 Jan. e23-e34. FI: 9.842000000000001
A gene-environment interaction analysis of plasma selenium with prevalent and incident diabetes: The Hortega study.
Galan-Chilet I, Grau-Perez M, De Marco G, Guallar E, Martin-Escudero JC, Dominguez-Lucas A, Gonzalez-Manzano I, Lopez-Izquierdo R, Briongos-Figuero LS, Redon J, Chaves FJ, Tellez-Plaza M
Redox biology.. 2017 Aug. 798-805. FI: 6.235
Cadmium body burden and increased blood pressure in middle-aged American Indians: the Strong Heart Study.
Franceschini N, Fry RC, Balakrishnan P, Navas-Acien A, Oliver-Williams C, Howard AG, Cole SA, Haack K, Lange EM, Howard BV, Best LG, Francesconi KA, Goessler W, Umans JG, Tellez-Plaza M
Journal of human hypertension.. 2017 Mar. 225-230. FI: 2.833
Dietary determinants of cadmium exposure in the Strong Heart Family Study.
Olmedo P, Grau-Perez M, Fretts A, Tellez-Plaza M, Gil F, Yeh F, Umans JG, Francesconi KA, Goessler W, Franceschini N, Lee ET, Best LG, Cole SA, Howard BV, Navas-Acien A
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.. 2017 Feb. 239-246. FI: 3.778
Identification of differentially methylated BRCA1 and CRISP2 DNA regions as blood surrogate markers for cardiovascular disease
Istas G, Declerck K, Pudenz M, Szic KSV, Lendinez-Tortajada V, Leon-Latre M, Heyninck K, Haegeman G, Casasnovas JA, Tellez-Plaza M, Gerhauser C, Heiss C, Rodriguez-Mateos A, Berghe WV.
Scientific reports. 2017 Jul 11. 5120. FI: 4.259
Multimorbidity and acute heart failure in internal medicine.
Martínez F, Martínez-Ibañez L, Pichler G, Ruiz A, Redon J
International journal of cardiology.. 2017 Apr 1. 208-2015. FI: 6.189
Urine cadmium levels and albuminuria in a general population from Spain: A gene-environment interaction analysis.
Grau-Perez M, Pichler G, Galan-Chilet I, Briongos-Figuero LS, Rentero-Garrido P, Lopez-Izquierdo R, Navas-Acien A, Weaver V, García-Barrera T, Gomez-Ariza JL, Martín-Escudero JC, Chaves FJ, Redon J, Tellez-Plaza M
Environment international.. 2017 Sep. 27-36. FI: 5.929
Very low level viraemia and risk of virological failure in treated HIV-1-infected patients.
Teira R, Vidal F, Muñoz-Sánchez P, Geijo P, Viciana P, Ribera E, Domingo P, Castaño M, Martínez E, Roca B, Puig T, Estrada V, Deig E, Galindo MJ, de la Fuente B, Lozano F, Montero M, Muñoz-Sanz A, Sanchez T, Terrón A, Romero-Palacios A, Lacalle JR, Garrido M, Suárez-Lozano I, VACH Study Group.
HIV medicine. 2017 Mar. 196-203. FI: 3.257
Real-life experience with sorafenib for the treatment of hepatocellular carcinoma in HIV-infected patients.
Merchante N, Ibarra S, Revollo B, Rodríguez-Arrondo F, Merino E, Delgado-Fernández M, Montero-Alonso M, Téllez F, Galindo MJ, Rivero-Juárez A, García MA, Mínguez C, Romero-Palacios A, Garcia-Deltoro M, Pineda JA, GEHEP-002 Study Group.
AIDS. 2017 Jan 2. 89-95. FI: 5.019
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants.
NCD Risk Factor Collaboration (NCD-RisC).
Lancet (London, England). 2017 Jan 7. 37-55. FI: 47.831
Eradication of HCV and non-liver-related non-AIDS-related events in HIV/HCV coinfection.
Berenguer J, Rodríguez-Castellano E, Carrero A, Von Wichmann MA, Montero M, Galindo MJ, Mallolas J, Crespo M, Téllez MJ, Quereda C, Sanz J, Barros C, Tural C, Santos I, Pulido F, Guardiola JM, Rubio R, Ortega E, Montes ML, Jusdado JJ, Gaspar G, Esteban H, Bellón JM, González-García J, GESIDA HIV/HCV Cohort Study Group.
Hepatology. 2017 Jan 21. 344-356. FI: 13.246
Identification of a large, fast-expanding HIV-1 subtype B transmission cluster among MSM in Valencia, Spain.
Patiño-Galindo JÁ, Torres-Puente M, Bracho MA, Alastrué I, Juan A, Navarro D, Galindo MJ, Gimeno C, Ortega E, González-Candelas F.
PloS one. 2017 Feb 2. e0171062. FI: 2.806
Correction: Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study.
Troya J, Ryan P, Ribera E, Podzamczer D, Hontañón V, Terrón JA, Boix V, Moreno S, Barrufet P, Castaño M, Carrero A, Galindo MJ, Suárez-Lozano I, Knobel H, Raffo M, Solís J, Yllescas M, Esteban H, González-García J, Berenguer J, Imaz A, GESIDA-8314 Study Group.
PloS one. 2017 Feb 9. e0172184. FI: 2.806
Donor-derived exosomes: key in lung allograft rejection?
Perez-Hernandez J, Cortes R.
Annals of translational medicine. 2017 Feb. 85
Hypertension: Controversies in blood-pressure goals among the elderly.
Redon J.
Nature reviews. Cardiology. 2017 Mar 14. 193-194. FI: 14.299
Extracellular Vesicles as Therapeutic Agents in Systemic Lupus Erythematosus.
Perez-Hernandez J, Redon J, Cortes R.
International journal of molecular sciences. 2017 Mar 28. . FI: 3.226
Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials.
Böhm M, Schumacher H, Teo KK, Lonn EM, Mahfoud F, Mann JF, Mancia G, Redon J, Schmieder RE, Sliwa K, Weber MA, Williams B, Yusuf S.
Lancet (London, England). 2017 Jun 3. 2226-2237. FI: 47.831
The polypill in cardiovascular prevention: evidence, limitations and perspective - position paper of the European Society of Hypertension.
Coca A, Agabiti-Rosei E, Cifkova R, Manolis AJ, Redón J, Mancia G.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension.. 2017 Aug. 1546-53. FI: 4.085
Clinical Perspective on Antihypertensive Drug Treatment in Adults With Grade 1 Hypertension and Low-to-Moderate Cardiovascular Risk: An International Expert Consultation.
Morales Salinas A, Coca A, Olsen MH, Sanchez RA, Sebba-Barroso WK, Kones R, Bertomeu-Martinez V, Sobrino J, Alcocer L, Pineiro DJ, Lanas F, Machado CA, Aguirre-Palacios F, Ortellado J, Perez G, Sabio R, Landrove O, Rodriguez-Leyva D, Duenas-Herrera A, Rodriguez Portelles A, Parra-Carrillo JZ, Piskorz DL, Bryce-Moncloa A, Waisman G, Yano Y, Ventura H, Orias M, Prabhakaran D, Sundström J, Wang J, Burrell LM, Schutte AE, Lopez-Jaramillo P, Barbosa E, Redon J, Weber MA, Lavie CJ, Ramirez A, Ordunez P, Yusuf S, Zanchetti A.
Current problems in cardiology. 2017 Jul. 198-225. FI: 2.217
Expertise: No Longer a Sine Qua Non for Guideline Authors?
Messerli FH, Hofstetter L, Agabiti-Rosei E, Burnier M, Elliott WJ, Franklin SS, Grodzicki T, Kario K, Kjeldsen SE, Kostis JB, Laurent S, Leenen FH, Lund-Johansen P, Mancia G, Narkiewicz K, Papademetriou V, Parati G, Poulter N, Redon J, Rimoldi SF, Ruilope LM, Schiffrin EL, Schmieder RE, Schwartz AB, Sever P, Sowers JR, Staessen JA, Wang J, Weber M, Williams B.
Hypertension. 2017 Aug. 235-237. FI: 6.857
Expertise: no longer a sine qua non for guideline authors?
Messerli FH, Hofstetter L, Agabiti-Rosei E, Burnier M, Elliott WJ, Franklin SS, Grodzicki T, Kario K, Kjeldsen SE, Kostis JB, Laurent S, Leenen FH, Lund-Johansen P, Mancia G, Narkiewicz K, Papademetriou V, Parati G, Poulter N, Redon J, Rimoldi SF, Ruilope LM, Schiffrin EL, Schmieder RE, Schwartz AB, Sever P, Sowers JR, Staessen JA, Wang J, Weber M, Williams B, de Leeuw PW.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension.. 2017 Aug. 1564-1566. FI: 4.085
Relative and Combined Prognostic Importance of On-Treatment Mean and Visit-to-Visit Blood Pressure Variability in ONTARGET and TRANSCEND Patients
Mancia G, Schumacher H, Böhm M, Redon J, Schmieder RE, Verdecchia P, Sleight P, Teo K, Yusuf S.
Hypertension. 2017 Nov. 938-48. FI: 6.857
Prognostic value of bone- and vascular-derived molecular biomarkers in hemodialysis and renal transplant patients: a systematic review and meta-analysis
Pichler G, Haller MC, Kainz A, Wolf M, Redon J, Oberbauer R.
Nephrology, dialysis, transplantation. 2017 Sep 1. 1566-1578. FI: 4.47
Noninvasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: a consensus article from the European Association of Cardiovascular Imaging, the European Society of Cardiology Council on Hypertension and the Eur
Perrone-Filardi P, Coca A, Galderisi M, Paolillo S, Alpendurada F, de Simone G, Donal E, Kahan T, Mancia G, Redon J, Schmieder R, Williams B, Agabiti-Rosei E.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension.. 2017 Sep. 1727-1741. FI: 4.085
Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: A consensus paper from the European Association of Cardiovascular Imaging (EACVI), the European Society of Cardiology Council on Hypertension, and
Perrone-Filardi P, Coca A, Galderisi M, Paolillo S, Alpendurada F, de Simone G, Donal E, Kahan T, Mancia G, Redon J, Schmieder R, Williams B, Agabiti-Rosei E.
European heart journal cardiovascular Imaging. 2017 Sep. 945-60. FI: 5.99
Reply
Messerli FH, Hofstetter L, Agabiti-Rosei E, Burnier M, Elliott WJ, Franklin SS, Grodzicki T, Kario K, Kjeldsen SE, Kostis JB, Laurent S, Leenen FH, de Leeuw PW, Lund-Johansen P, Mancia G, Narkiewicz K, Papademetriou V, Parati G, Poulter N, Redon J, Rimoldi SF, Ruilope LM, Schiffrin EL, Schmieder RE, Schwartz AB, Sever P, Sowers JR, Staessen JA, Wang J, Weber M, Williams B.
Journal of hypertension. 2017 Nov. 2327-2328. FI: 4.085
2016 European guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representati
Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FDR, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WMM.
Giornale italiano di cardiologia. 2017 Jul-Aug. 547-612
Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults
NCD Risk Factor Collaboration (NCD-RisC).
Lancet (London, England). 2017 Dec 16. 2627-2642. FI: 47.831
Declining exposures to lead and cadmium contribute to explain the reduction of cardiovascular mortality in the US population, 1988-2004
Ruiz-Hernandez A1,2, Navas-Acien A3,4,5, Pastor-Barriuso R6,7, Crainiceanu CM8, Redon J1,2,9, Guallar E3,5,10, Tellez-Plaza M2,4.
International journal of epidemiology. 2017 Dec 1. 1903-1912. FI: 7.738
Reply
Mancia G, Coca A, Agabiti-Rosei E, Cifkova R, Manolis AJ, Redon J.
Journal of hypertension. 2017 Dec. 2551-2552. FI: 4.085
Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study
Orozco-Beltran D1, Gil-Guillen VF1, Redon J2,3,4, Martin-Moreno JM5, Pallares-Carratala V6, Navarro-Perez J2,3,7, Valls-Roca F8, Sanchis-Domenech C9, Fernandez-Gimenez A10, Perez-Navarro A10, Bertomeu-Martinez V11,12, Bertomeu-Gonzalez V11,12, Cordero A11,12, Pascual de la Torre M13, Trillo JL14, Carratala-Munuera C1, Pita-Fernandez S15, Uso R16, Durazo-Arvizu R17, Cooper R17, Sanz G18, Castellano JM18,19, Ascaso JF20,21, Carmena R20,21, Tellez-Plaza M22,23; ESCARVAL Study Group.
PloS one. 2017 Oct 18. e0186196. FI: 2.806
Complexity Levels in Patients With Heart Failure Diagnostic Codes in a Population
Navarro J, Calabuig J, Usó R, Redón J, Sanchis J, Núñez J
Revista española de cardiología (English ed.). 2017 Jul 25. S1885-5857(17)30272-4. FI: 4.485
Reply.
Lurbe E, Redon J
Journal of hypertension. Supplement: official journal of the International Society of Hypertension.. 2016 Oct. 2102. FI: 5.062
The risk of visit-to-visit blood pressure variability in chronic kidney disease: cause or consequence.
Redon J
Journal of hypertension. Supplement: official journal of the International Society of Hypertension.. 2016 Feb. 188-90. FI: 4.72
Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.
Hofstra LM, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, Van de Vijver DA, Åsjö B, Beshkov D, Coughlan S, Descamps D, Griskevicius A, Hamouda O, Horban A, Van Kasteren M, Kolupajeva T, Kostrikis LG, Liitsola K, Linka M, Mor O, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M, Puchhammer-Stöckl E, Sönnerborg A, Staneková D, Stanojevic M, Van Laethem K, Zazzi M, Zidovec Lepej S, Boucher CA, Schmit JC, Wensing AM, SPREAD Program
Clinical infectious diseases: an official publication of the Infectious Diseases Society of America.. 2016 Mar 1. 655-63. FI: 8.885999999999999
Treatment of high blood pressure in elderly and octogenarians: European Society of Hypertension statement on blood pressure targets.
Kjeldsen SE, Stenehjem AE, Os I, Van de Borne P, Burnier M, Narkiewicz K, Redon J, Agabiti Rosei E, Mancia G
Blood pressure.. 2016 Sep 20. 42675. FI: 2.01
Treatment of hypertension and the price to pay; adverse events and discontinuation from randomized treatment in clinical trials.
Kjeldsen SE, Os I, Redon J
Journal of hypertension. Supplement: official journal of the International Society of Hypertension.. 2016 Aug. 1489-91. FI: 5.062
Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants.
NCD Risk Factor Collaboration (NCD-RisC), Di Cesare M, Bentham J, Stevens GA, Zhou B, Danaei G, Lu Y, Bixby H, Cowan MJ, Riley LM, Hajifathalian K, Fortunato L, Taddei C, Bennett JE, Ikeda N, Khang YH, Kyobutungi C, Laxmaiah A, Li Y, Lin HH, Miranda JJ, Mostafa A, Turley ML, Paciorek CJ, Gunter M, Ezzati M
Lancet.. 2016 Apr 2. 1377-96. FI: 45.217
Urinary dedifferentiated podocytes as a non-invasive biomarker of lupus nephritis.
Perez-Hernandez J, Olivares MD, Forner MJ, Chaves FJ, Cortes R, Redon J
Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association.. 2016 May. 780-9. FI: 3.577
Why in 2016 are patients with hypertension not 100% controlled? A call to action.
Redon J, Mourad JJ, Schmieder RE, Volpe M, Weiss TW
Journal of hypertension. Supplement: official journal of the International Society of Hypertension.. 2016 Jun 6. . FI: 5.062
Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants.
NCD Risk Factor Collaboration (NCD-RisC)
Lancet.. 2016 Apr 9. 1513-30. FI: 45.217
A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension.
Olsen MH, Angell SY, Asma S, Boutouyrie P, Burger D, Chirinos JA, Damasceno A, Delles C, Gimenez-Roqueplo AP, Hering D, López-Jaramillo P, Martinez F, Perkovic V, Rietzschel ER, Schillaci G, Schutte AE, Scuteri A, Sharman JE, Wachtell K, Wang JG
Lancet.. 2016 Nov 26. 2665-2712. FI: 47.831
Estimation of Inorganic Arsenic Exposure in Populations With Frequent Seafood Intake: Evidence From MESA and NHANES
Jones MR, Tellez-Plaza M, Vaidya D, Grau M, Francesconi KA, Goessler W, Guallar E, Post WS, Kaufman JD, Navas-Acien A.
American journal of epidemiology. 2016 Oct 15. 590-562. FI: 4.825
OP.2A.01 Urine cadmium levels and albuminuria in a general population from spain: a gene-environment interaction population-based study.
Pichler G, Grau-Perez M, Martin-Escudero J, Galan-Chilet I, Dominguez-Lucas A, Chaves F, Redon J, Tellez-Plaza M
Journal of hypertension. Supplement : official journal of the International Society of Hypertension.. 2016 Sep. e15. FI: 5.062
OP.7B.03 Blood pressure and obesity metabolomic stratified analysis of a spanish general population.
Marrachelli V, Monleon D, Morales JM, Martínez F, Martin-Escudero JC, Redon J
Journal of hypertension. Supplement : official journal of the International Society of Hypertension.. 2016 Sep. e86. FI: 5.062
Peripheral Arterial Disease and Its Association With Arsenic Exposure and Metabolism in the Strong Heart Study.
Newman JD, Navas-Acien A, Kuo CC, Guallar E, Howard BV, Fabsitz RR, Devereux RB, Umans JG, Francesconi KA, Goessler W, Best LT, Tellez-Plaza M
American journal of epidemiology.. 2016 Dec 1. 806-817. FI: 4.825
Pulse pressure amplification and its determinants.
Pichler G, Martinez F, Vicente A, Solaz E, Calaforra O, Redon J
Blood pressure.. 2016 Feb. 43282. FI: 1.808
Renal function and attributable risk of death and cardiovascular hospitalization in patients with cardiovascular risk factors from a registry-based cohort: the Estudio Cardiovascular Valencia-risk study.
Tellez-Plaza M, Orozco-Beltran D, Gil-Guillen V, Pita-Fernandez S, Navarro-Pérez J, Pallares V, Valls F, Fernandez A, Perez-Navarro AM, Sanchis C, Dominguez-Lucas A, Martin-Moreno JM, Redon J, ESCARVAL STUDY GROUP.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension.. 2016 Nov. 2266-73. FI: 5.062
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representati
Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FD, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WM, Authors/Task Force Members
European heart journal.. 2016 May 23. . FI: 15.203
Methodology and technology for peripheral and central blood pressure and blood pressure variability measurement: current status and future directions - Position statement of the European Society of Hypertension Working Group on blood pressure monitoring a
Stergiou GS, Parati G, Vlachopoulos C, Achimastos A, Andreadis E, Asmar R, Avolio A, Benetos A, Bilo G, Boubouchairopoulou N, Boutouyrie P, Castiglioni P, de la Sierra A, Dolan E, Head G, Imai Y, Kario K, Kollias A, Kotsis V, Manios E, McManus R, Mengden T, Mihailidou A, Myers M, Niiranen T, Ochoa JE, Ohkubo T, Omboni S, Padfield P, Palatini P, Papaioannou TG, Protogerou A, Redon J, Verdecchia P, Wang J, Zanchetti A, Mancia G, O'Brien E
Journal of hypertension. Supplement: official journal of the International Society of Hypertension.. 2016 May 20. . FI: 4.72
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representati
Authors/Task Force Members, Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FD, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WM, Additional Contributor: Simone Binno (Italy), Document Reviewers:, De Backer G, Roffi M, Aboyans V, Bachl N, Bueno H, Carerj S, Cho L, Cox J, De Sutter J, Egidi G, Fisher M, Fitzsimons D, Franco OH, Guenoun M, Jennings C, Jug B, Kirchhof P, Kotseva K, Lip GY, Mach F, Mancia G, Bermudo FM, Mezzani A, Niessner A, Ponikowski P, Rauch B, Rydén L, Stauder A, Turc G, Wiklund O, Windecker S, Zamorano JL
European journal of preventive cardiology.. 2016 Jul. NP1-NP96. FI: 3.361
[OP.6A.06] Vascular phenotypes by assessing peripheral and central blood pressure in obese youth.
Lurbe E, Torro MI, Alvarez-Pitti J, Redon P, Redon J
Journal of hypertension. Supplement: official journal of the International Society of Hypertension.. 2016 Sep. e67-8. FI: 5.062
A century of trends in adult human height.
NCD Risk Factor Collaboration (NCD-RisC)
eLife. 2016 Jul 26. . FI: 8.303000000000001
Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study.
Troya J, Ryan P, Ribera E, Podzamczer D, Hontañón V, Terrón JA, Boix V, Moreno S, Barrufet P, Castaño M, Carrero A, Galindo MJ, Suárez-Lozano I, Knobel H, Raffo M, Solís J, Yllescas M, Esteban H, González-García J, Berenguer J, Imaz A, GESIDA-8314 Study Group.
PLoS hub for clinical trials. 2016 Oct 11. e0164455. FI: 3.057
AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation.
Bousquet J, Barbara C, Bateman E, Bel E, Bewick M, Chavannes NH, Cruz AA, Haahtela T, Hellings PW, Khaltaev N, Lodrup Carlsen K, Muraro A, Cordeiro CR, Rosado-Pinto J, Samolinski B, Strandberg T, Valiulis A, Yorgancioglu A, Zuberbier T, AIRWAYS-ICPs working group
The European respiratory journal. Supplement.. 2016 Apr. 1028-33. FI: 8.332000000000001
An Expert Opinion From the European Society of Hypertension-European Union Geriatric Medicine Society Working Group on the Management of Hypertension in Very Old, Frail Subjects.
Benetos A, Bulpitt CJ, Petrovic M, Ungar A, Agabiti Rosei E, Cherubini A, Redon J, Grodzicki T, Dominiczak A, Strandberg T, Mancia G
Hypertension.. 2016 May. 820-5. FI: 6.499
Analysing the concept of diagnostic inertia in hypertension: a cross-sectional study.
Pallares-Carratalá V, Bonig-Trigueros I, Palazón-Bru A, Lorenzo-Piqueres A, Valls-Roca F, Orozco-Beltrán D, Gil-Guillen VF, Steering Committee ESCARVAL Study
International journal of clinical practice.. 2016 May 10. . FI: 2.566
Association of Geography and Ambient Air Pollution with Urine Metal Concentrations in Six US Cities: The Multi-Ethnic Study of Atherosclerosis.
Pang Y, Jones MR, Tellez-Plaza M, Guallar E, Vaidya D, Post WS, Kaufman JD, Delaney JA, Navas-Acien A
International journal of environmental research and public health. 2016 Mar 15.
Comparative Study of the Efficacy of Olmesartan/Amlodipine vs. Perindopril/Amlodipine in Peripheral and Central Blood Pressure Parameters After Missed Dose in Type 2 Diabetes.
Redon J, Pichler G, Missed Dose Study Group
American journal of hypertension.. 2016 May 24. . FI: 2.852
Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabetes.
Redon J, Pichler G, Missed Dose Study Group
Journal of hypertension. Supplement: official journal of the International Society of Hypertension.. 2016 Feb. 359-67. FI: 4.72
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke.
Zanchetti A, Liu L, Mancia G, Parati G, Grassi G, Stramba-Badiale M, Silani V, Bilo G, Corrao G, Zambon A, Scotti L, Zhang X, Guan TR, Zhang Y, Zhang X, Berge E, Redon J, Narkiewicz K, Dominiczak A, Nilsson P, Viigimaa M, Laurent S, Agabiti-Rosei E, Wu Z, Zhu D, Rodicio JL, Ruilope LM, Martell-Claros N, Pinto F, Schmieder RE, Burnier M, Banach M, Cifkova R, Farsang C, Konradi A, Lazareva I, Sirenko Y, Dorobantu M, Postadzhiyan A, Accetto R, Jelakovic B, Lovic D, Manolis AJ, Stylianou P, Dicker D, Wei G, Xu C, Xie H, Coca A, O'Brien J, Ford G, ESH-CHL-SHOT trial investigators
Journal of hypertension. Supplement: official journal of the International Society of Hypertension.. 2016 Mar. 393-6. FI: 4.72
Environmental Metals and Cardiovascular Disease in Adults: A Systematic Review Beyond Lead and Cadmium.
Nigra AE, Ruiz-Hernandez A, Redon J, Navas-Acien A, Tellez-Plaza M
Current environmental health reports.. 2016 Oct 25.
Executive summary of the consensus document on psychiatric and psychological aspects in adults and children with HIV infection.
Experts Panel from the Secretary of the National AIDS Plan (SPNS), Spanish Society of Psychiatry (SEP), AIDS Study Group (GeSIDA), Spanish Society of Pediatric Infectious Diseases (SEIP). Electronic address: rpolor@msssi.es
Enfermedades infecciosas y microbiología clínica.. 2016 Jan. 54-60. FI: 2.172
Executive Summary of the Joint Position Paper on Renal Denervation of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) and the European Society of Hypertension (ESH).
Moss JG, Belli AM, Coca A, Lee M, Mancia G, Peregrin JH, Redon J, Reekers JA, Tsioufis C, Vorwerk D, Schmieder RE
Cardiovascular and interventional radiology.. 2016 Sep 22. . FI: 2.144
Executive summary of the joint position paper on renal denervation of the Cardiovascular and Interventional Radiological Society of Europe and the European Society of Hypertension.
Moss JG, Belli AM, Coca A, Lee M, Mancia G, Peregrin JH, Redon J, Reekers JA, Tsioufis C, Vorwerk D, Schmieder RE
Journal of hypertension. Supplement: official journal of the International Society of Hypertension.. 2016 Oct 17. . FI: 5.062
Global Cardiovascular Risk Assessment: Strengths and Limitations.
Redon J
High blood pressure & cardiovascular prevention: the official journal of the Italian Society of Hypertension.. 2016 Mar 18.
Impact of hypertension on mortality and cardiovascular disease burden in patients with cardiovascular risk factors from a general practice setting: the ESCARVAL-risk study.
Redon J, Tellez-Plaza M, Orozco-Beltran D, Gil-Guillen V, Pita Fernandez S, Navarro-Pérez J, Pallares V, Valls F, Fernandez A, Perez-Navarro AM, Sanchis C, Dominguez-Lucas A, Sanz G, Martin-Moreno JM, ESCARVAL Study Group
Journal of hypertension. Supplement : official journal of the International Society of Hypertension.. 2016 Jun. 1075-83. FI: 5.062
Isolated Systolic Hypertension in Young People Is Not Spurious and Should Be Treated: Con Side of the Argument.
Lurbe E, Redon J
Hypertension.. 2016 Jun 20. . FI: 6.294
JS ISH-ESH-1 EVALUATION OF RENAL FUNCTION AT BASELINE AND DURING TREATMENT.
Redon J
Journal of hypertension. Supplement: official journal of the International Society of Hypertension.. 2016 Sep. e192. FI: 5.062
Panethnic Differences in Blood Pressure in Europe: A Systematic Review and Meta-Analysis.
Modesti PA, Reboldi G, Cappuccio FP, Agyemang C, Remuzzi G, Rapi S, Perruolo E, Parati G, ESH Working Group on CV Risk in Low Resource Settings
PLoS hub for clinical trials. 2016. e0147601. FI: 3.234
6C.04: Integrated SNP analysis and metabolomic profiles of metabolic syndrome.
Marrachelli V, Monleon D, Morales JM, Rentero P, Martínez F, Chaves FJ, Martin-Escudero JC, Redon J
Journal of hypertension. 2015 Jun. e80. FI: 4.72
DNA methylation patterns in newborns exposed to tobacco in utero.
Ivorra C, Fraga MF, Bayón GF, Fernández AF, Garcia-Vicent C, Chaves F, Redon J, Lurbe E
Journal of translational medicine. 2015 Jan 27. 25. FI: 3.93
Do genes modify the association of selenium and lipid levels?
Galan-Chilet I, Guallar E, Martin-Escudero JC, De Marco G, Dominguez-Lucas A, Gonzalez-Manzano I, Lopez-Izquierdo R, Redon J, Chaves FJ, Tellez-Plaza M
Antioxidants & redox signaling. 2015 May 20. 1352-62. FI: 7.093
Extracellular Vesicles as Biomarkers of Systemic Lupus Erythematosus.
Perez-Hernandez J, Cortes R
Disease markers.. 2015. 613536. FI: 1.562
Consensus statement on metabolic disorders and cardiovascular risks in patients with human immunodeficiency virus.
Grupo de expertos del Grupo de Estudio sobre Alteraciones Metabólicas (GEAM), de la Secretaría del Plan Nacional sobre el Sida (SPNS) y del Grupo de Estudio de Sida (GeSIDA), Polo Rodríguez R, Galindo Puerto MJ, Dueñas C, Gómez Candela C, Estrada V, Villar NG, Locutura J, Mariño A, Pascua J, Palacios R, von Wichmman MÁ, Álvarez J, Asensi V, Lopez Aldeguer J, Lozano F, Negredo E, Ortega E, Pedrol E, Gutiérrez F, Sanz Sanz J, Martínez Chamorro E
Enfermedades infecciosas y microbiologia clinica. 2015 Jan. 40.e1-40.e16. FI: 2.172
Barriers to ART initiation in HIV infected subjects and with treatment indication in Spain. Why don't they start their treatment? Bridgap Study.
Viciana-Fernández P, Falcó V, Castaño M, de los Santos-Gil I, Olalla-Sierra J, Hernando A, Deig E, Clotet B, Knobel H, Podzamczer D, Pedrol PD, Grupo de trabajo Bridgap
Enfermedades infecciosas y microbiología clínica.. 2015 Jun-Jul. 397-403. FI: 2.172
2A.06: COMPARATIVE STUDY OF THE EFFICACY OF OLMESARTAN/AMLODIPINE VERSUS PERINDOPRIL/AMLODIPINE IN PERIPHERAL AND CENTRAL BP PARAMETERS AFTER MISSED DOSE IN TYPE 2 DIABETES.
Redon J, Team MD
Journal of hypertension. 2015 Jun. e20-1. FI: 4.72
2B.04: FACTORS RELATED TO THE LINK BETWEEN URIC ACID AND SYSTOLIC BLOOD PRESSURE IN YOUTHS.
Torro MI, Alvarez J, Aguilar F, Redon P, Lurbe E
Journal of hypertension. 2015 Jun. e23. FI: 4.72
3A.05: Hypertension and risk of events associated to reduced EGFR. The escarval-risk study.
Tellez-Plaza M, Orozco-Beltran D, Gil-Guillen V, Navarro-Pérez J, Pallares V, Valls F, Fernandez A, Martin-Moreno JM, Sanchis C, Dominguez-Lucas A, Redon J
Journal of hypertension. 2015 Jun. e32-3. FI: 4.72
Association of baseline CD4+ cell count and HIV-RNA on sustained virologic response to interferon-ribavirin in HIV/HCV coinfected patients.
Aldámiz-Echevarría T, González-García J, Von Wichmann MA, Crespo M, López-Aldeguer J, Quereda C, Téllez MJ, Galindo MJ, Sanz J, Santos I, Guardiola JM, Bellón JM, Montes M, Berenguer J
Annals of hepatology. 2015 Jul-Aug. 464-9. FI: 2.065
Carotid-femoral pulse wave velocity assessment by two different methods: implications for risk assessment.
Pichler G, Martinez F, Vicente A, Solaz E, Calaforra O, Redon J
Journal of hypertension. 2015 Sep. 1868-75. FI: 4.72
Combining -omics in the search for mechanisms in complex trait diseases.
Redón J, Monleón D
Journal of hypertension. 2015 Apr. 698-9. FI: 4.72
Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus.
Berenguer J, Zamora FX, Aldámiz-Echevarría T, Von Wichmann MA, Crespo M, López-Aldeguer J, Carrero A, Montes M, Quereda C, Téllez MJ, Galindo MJ, Sanz J, Santos I, Guardiola JM, Barros C, Ortega E, Pulido F, Rubio R, Mallolas J, Tural C, Jusdado JJ, Pérez G, Díez C, Álvarez-Pellicer J, Esteban H, Bellón JM, González-García J, Grupo de Estudio del SIDA (GESIDA) HIV/HCV Cohort Study Group
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2015 Mar 15. 950-8. FI: 8.885999999999999
Different strategies from monotherapies to dual or triple fixed dose combination therapies to achieve blood pressure goals: a summary of a satellite symposium from the European Society of Hypertension, June 13-16, 2014 Athens, Greece. Introduction.
Redon J
High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension.. 2015 Jul. S3-4
Efavirenz and the CNS: what we already know and questions that need to be answered.
Apostolova N, Funes HA, Blas-Garcia A, Galindo MJ, Alvarez A, Esplugues JV
The Journal of antimicrobial chemotherapy.. 2015 Oct. 2693-708. FI: 5.313
Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331,288 participants.
NCD Risk Factor Collaboration (NCD-RisC)
The lancet. Diabetes & endocrinology.. 2015 Aug. 624-37. FI: 9.185
Environmental chemicals and DNA methylation in adults: a systematic review of the epidemiologic evidence.
Ruiz-Hernandez A, Kuo CC, Rentero-Garrido P, Tang WY, Redon J, Ordovas JM, Navas-Acien A, Tellez-Plaza M
Clinical epigenetics. 2015. 55
Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV infection.
Panel of experts from the Metabolic Disorders Study Group (GEAM), National Aids Plan (SPNS), Aids Study Group (GeSIDA), Polo Rodríguez R, Galindo Puerto MJ, Dueñas C, Gómez Candela C, Estrada V, Villar NG, Locutura J, Mariño A, Pascua J, Palacios R, Von Wichmman MÁ, Álvarez J, Asensi V, Lopez Aldeguer J, Lozano F, Negredo E, Ortega E, Pedrol E, Gutiérrez F, Sanz Sanz J, Martínez Chamorro E
Enfermedades infecciosas y microbiologia clinica. 2015 Jan. 41-7. FI: 2.172
Expansion of the CRF19_cpx Variant in Spain.
Patiño Galindo JA, Torres-Puente M, Gimeno C, Ortega E, Navarro D, Galindo MJ, Navarro L, Navarro V, Juan A, Belda J, Bracho MA, González-Candelas F, CRIVIH
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2015 Aug. 146-9. FI: 3.016
Increased Urinary Exosomal MicroRNAs in Patients with Systemic Lupus Erythematosus.
Perez-Hernandez J, Forner MJ, Pinto C, Chaves FJ, Cortes R, Redon J
PLoS hub for clinical trials. 2015. e0138618. FI: 3.234
Influence of obesity in central blood pressure.
Pichler G, Martinez F, Vicente A, Solaz E, Calaforra O, Lurbe E, Redon J
Journal of hypertension. 2015 Feb. 308-13. FI: 4.72
Linkage Analysis of Urine Arsenic Species Patterns in the Strong Heart Family Study.
Gribble MO, Voruganti VS, Cole SA, Haack K, Balakrishnan P, Laston SL, Tellez-Plaza M, Francesconi KA, Goessler W, Umans JG, Thomas DC, Gilliland F, North KE, Franceschini N, Navas-Acien A
Toxicological sciences : an official journal of the Society of Toxicology.. 2015 Nov. 89-100. FI: 3.854
New developments in the pathogenesis of obesity-induced hypertension.
Kotsis V, Nilsson P, Grassi G, Mancia G, Redon J, Luft F, Schmieder R, Engeli S, Stabouli S, Antza C, Pall D, Schlaich M, Jordan J, WG on Obesity, Diabetes, the High Risk Patient, European Society of Hypertension
Journal of hypertension. 2015 Aug. 1499-508. FI: 4.72
Primary resistance to integrase strand-transfer inhibitors in Europe.
Casadellà M, van Ham PM, Noguera-Julian M, van Kessel A, Pou C, Hofstra LM, Santos JR, Garcia F, Struck D, Alexiev I, Bakken Kran AM, Hoepelman AI, Kostrikis LG, Somogyi S, Liitsola K, Linka M, Nielsen C, Otelea D, Paraskevis D, Poljak M, Puchhammer-Stöckl E, Staneková D, Stanojevic M, Van Laethem K, Zidovec Lepej S, Clotet B, Boucher CA, Paredes R, Wensing AM, SPREAD programme
The Journal of antimicrobial chemotherapy.. 2015 Oct. 2885-8. FI: 5.313
Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design.
Mahfoud F, Böhm M, Azizi M, Pathak A, Durand Zaleski I, Ewen S, Tsioufis K, Andersson B, Blankestijn PJ, Burnier M, Chatellier G, Gafoor S, Grassi G, Joner M, Kjeldsen SE, Lüscher TF, Lobo MD, Lotan C, Parati G, Redon J, Ruilope L, Sudano I, Ukena C, van Leeuwen E, Volpe M, Windecker S, Witkowski A, Wijns W, Zeller T, Schmieder RE
European heart journal.. 2015 Sep 1. 2219-27. FI: 15.203
Reply.
Pichler G, Martinez F, Redon J
Journal of hypertension. Supplement : official journal of the International Society of Hypertension.. 2015 Dec. 2551. FI: 4.72
Systolic blood pressure variation and mean heart rate is associated with cognitive dysfunction in patients with high cardiovascular risk.
Böhm M, Schumacher H, Leong D, Mancia G, Unger T, Schmieder R, Custodis F, Diener HC, Laufs U, Lonn E, Sliwa K, Teo K, Fagard R, Redon J, Sleight P, Anderson C, O'Donnell M, Yusuf S
Hypertension.. 2015 Mar. 651-61. FI: 6.48
The kidney in obesity.
Redon J, Lurbe E
Current hypertension reports. 2015 Jun. 555. FI: 3.435
Unusual Case of Severe Hypertension in a 20-Year-Old Woman.
Pichler G, Martinez F, Fernandez C, Redon J
Hypertension.. 2015 Dec. 1093-7. FI: 6.48
Within-visit BP variability, cardiovascular risk factors, and BP control in central and eastern Europe: findings from the BP-CARE study.
Grassi G, Seravalle G, Maloberti A, Facchetti R, Cuspidi C, Bombelli M, Laurent S, Redon J, Mancia G
Journal of hypertension. Supplement : official journal of the International Society of Hypertension.. 2015 Nov. 2250-6. FI: 4.72
The nutrigenetic influence of the interaction between dietary vitamin E and TXN and COMT gene polymorphisms on waist circumference: a case control study.
Mansego ML, De Marco G, Ivorra C, Lopez-Izquierdo R, Morcillo S, Rojo-Martínez G, González-Albert V, Martinez F, Soriguer F, Martín-Escudero JC, Redon J, Chaves FJ
Journal of translational medicine. 2015 Sep 2. 286. FI: 3.93
HIV/hepatitis C virus-coinfected patients who achieved sustained virological response are still at risk of developing hepatocellular carcinoma.
Merchante N, Merino E, Rodríguez-Arrondo F, Tural C, Muñoz J, Delgado-Fernández M, Jover F, Galindo MJ, Rivero A, López-Aldeguer J, Aguirrebengoa K, Romero-Palacios A, Martínez E, Pineda JA
AIDS (London, England). 2014 Jan 2. 41-7. FI: 6.557
2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension.
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F
Blood pressure. 2014 Feb. 42430. FI: 1.605
Impact of abdominal obesity and ambulatory blood pressure in the diagnosis of left ventricular hypertrophy in never treated hypertensives.
Rodilla E, Costa JA, Martín J, González C, Pascual JM, Redon J
Medicina clínica. 2014 Mar 20. 235-42. FI: 1.252
Is the physician's behavior in dyslipidemia diagnosis in accordance with guidelines? Cross-sectional ESCARVAL study.
Palazón-Bru A, Gil-Guillén VF, Orozco-Beltrán D, Pallarés-Carratalá V, Valls-Roca F, Sanchís-Domenech C, Martín-Moreno JM, Redón J, Navarro-Pérez J, Fernández-Giménez A, Pérez-Navarro AM, Trillo JL, Usó R, Ruiz E
PloS one. 2014. e91567. FI: 3.534
Improving Knowledge of Arterial Resistant Hypertension: What Is Relevant?
Redon J
Revista española de cardiología. 2014 Apr. 251-253. FI: 3.342
What the interventionalist should know about renal denervation in hypertensive patients: a position paper by the ESH WG on the interventional treatment of hypertension.
Tsioufis C, Mahfoud F, Mancia G, Redon J, Damascelli B, Zeller T, Schmieder RE
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2014 Jan 22. 1027-35. FI: 3.758
Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis.
Schulman S, Kakkar AK, Goldhaber SZ, Schellong S, Eriksson H, Mismetti P, Christiansen AV, Friedman J, Le Maulf F, Peter N, Kearon C, RE-COVER II Trial Investigators
Circulation. 2014 Feb 18. 764-72. FI: 14.948
Effects of nebivolol and atenolol on central aortic pressure in hypertensive patients: a multicenter, randomized, double-blind study.
Redón J, Pascual-Izuel JM, Rodilla E, Vicente A, Oliván J, Bonet J, Torguet JP, Calaforra O, Almirall J
Blood pressure. 2014 Jun. 181-8. FI: 1.605
Associations of birth weight and postnatal weight gain with cardiometabolic risk parameters at 5 years of age.
Lurbe E, Garcia-Vicent C, Torro MI, Aguilar F, Redon J
Hypertension. 2014 Jun. 1326-32. FI: 7.632
European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring.
Parati G, Stergiou G, O'Brien E, Asmar R, Beilin L, Bilo G, Clement D, de la Sierra A, de Leeuw P, Dolan E, Fagard R, Graves J, Head GA, Imai Y, Kario K, Lurbe E, Mallion JM, Mancia G, Mengden T, Myers M, Ogedegbe G, Ohkubo T, Omboni S, Palatini P, Redon J, Ruilope LM, Shennan A, Staessen JA, vanMontfrans G, Verdecchia P, Waeber B, Wang J, Zanchetti A, Zhang Y
Journal of hypertension. 2014 Jul. 1359-66. FI: 4.222
Improving knowledge of arterial resistant hypertension: what is relevant?
Redon J
Revista española de cardiología (English ed.). 2014 Apr. 251-3
Cadmium exposure and cancer mortality in a prospective cohort: the strong heart study.
García-Esquinas E, Pollan M, Tellez-Plaza M, Francesconi KA, Goessler W, Guallar E, Umans JG, Yeh J, Best LG, Navas-Acien A
Environmental health perspectives. 2014 Apr. 363-70. FI: 7.977
Target blood pressure in elderly hypertensive patients and in patients with diabetes mellitus.
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Chairpersons and Section Coordinators of the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and European Society of Cardiology (ESC)
Journal of hypertension. 2014 Aug. 1551-2. FI: 4.222
Genomic and metabolomic profile associated to microalbuminuria.
Marrachelli VG, Monleon D, Rentero P, Mansego ML, Morales JM, Galan I, Segura R, Martinez F, Martin-Escudero JC, Briongos L, Marin P, Lliso G, Chaves FJ, Redon J
PloS one. 2014. e98227. FI: 3.534
Effects of Sustained Viral Response in Patients With HIV and Chronic Hepatitis C and Nonadvanced Liver Fibrosis.
Berenguer J, Zamora FX, Carrero A, Von Wichmann MA, Crespo M, López-Aldeguer J, Aldámiz-Echevarría T, Montes M, Quereda C, Téllez MJ, Galindo MJ, Sanz J, Santos I, Guardiola JM, Esteban H, Bellón JM, González-García J, GESIDA HIVHCV Cohort Study Group
Journal of acquired immune deficiency syndromes (1999). 2014 Jul 1. 280-7. FI: 4.394
Establishing reference values for central blood pressure and its amplification in a general healthy population and according to cardiovascular risk factors
Herbert A, Cruickshank JK, Laurent S, Boutouyrie P; Reference Values for Arterial Measurements Collaboration.
European heart journal. 2014 Nov 21. 3122-3133. FI: 20.212
Risk factors associated with retinal vein occlusion
Martínez F, Furió E, Fabiá MJ, Pérez AV, González-Albert V, Rojo-Martínez G, Martínez-Larrad MT, Mena-Martín FJ, Soriguer F, Serrano-Ríos M, Chaves FJ, Martín-Escudero JC, Redón J, García-Fuster MJ.
International journal of clinical practice. 2014 Jul. 871-881. FI: 2.14
Consensus statement on the clinical management of human immunodeficiency virus-associated neurocognitive disorders.
Grupo de expertos del Grupo de Estudio de Sida (GeSIDA) y de la Secretaría del Plan Nacional sobre el Sida (SPNS), Podzamczer Palter D, Muñoz-Moreno JA, Alcolea Rodríguez D, Alonso Villaverde C, Antela López A, Blanch Andreu J, Casado Osorio JL, Galindo Puerto MJ, Garolera i Freixa M, Locutura Rupérez J, Lleó Bisa A, Prats París A, Pérez-Valero I, Portilla Sogorb J, Rovira Cañellas A, Téllez Molina MJ, Tiraboschi JM, Vergara Moragues E, Arribas López JR, Goenaga Sánchez MÁ, de León-Naranjo FL, Martínez Chamorro E, Polo Rodríguez R, Muñoz-Moreno JA, Podzamczer D
Enfermedades infecciosas y microbiologia clinica. 2014 Jan. 37-47. FI: 1.881
Consensus statement on assistance to women with human immunodeficiency virus infection in the health care sector. National AIDS Plan (PNS) and AIDS Study Group (GeSIDA).
Plan Nacional sobre el Sida (PNS), Grupo de Estudio de Sida (GeSIDA)
Enfermedades infecciosas y microbiologia clinica. 2014 Feb. 99.e1-99.e14. FI: 1.881
Executive summary of the recommendations on the evaluation and management of renal disease in human immunodeficiency virus-infected patients.
Panel de Expertos del Grupo de Estudio de Sida (GESIDA), la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC), la Sociedad Española de Nefrología (SEN), la Sociedad Española de Bioquímica Clínica y Patología Molecular (SEQC), Gorriz JL, Gutiérrez F, Trullàs JC, Arazo P, Arribas JR, Barril G, Cervero M, Cofán F, Domingo P, Estrada V, Fulladosa X, Galindo MJ, Gràcia S, Iribarren JA, Knobel H, López-Aldeguer J, Lozano F, Martínez-Castelao A, Martínez E, Mazuecos MA, Miralles C, Montañés R, Negredo E, Palacios R, Pérez-Elías MJ, Portilla J, Praga M, Quereda C, Rivero A, Santamaría JM, Sanz J, Sanz J, Miró JM
Enfermedades infecciosas y microbiología clínica. 2014 Nov. 583-97. FI: 1.881
Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomize
Zanchetti A, Liu L, Mancia G, Parati G, Grassi G, Stramba-Badiale M, Silani V, Bilo G, Corrao G, Zambon A, Scotti L, Zhang X, Wang H, Zhang Y, Zhang X, Guan TR, Berge E, Redon J, Narkiewicz K, Dominiczak A, Nilsson P, Viigimaa M, Laurent S, Agabiti-Rosei E, Wu Z, Zhu D, Rodicio JL, Ruilope LM, Martell-Claros N, Pinto F, Schmieder RE, Burnier M, Banach M, Cifkova R, Farsang C, Konradi A, Lazareva I, Sirenko Y, Dorobantu M, Postadzhiyan A, Accetto R, Jelakovic B, Lovic D, Manolis AJ, Stylianou P, Erdine S, Dicker D, Wei G, Xu C, Xie H, Coca A, O'Brien J, Ford G
Journal of hypertension. 2014 Sep. 1888-97. FI: 4.222
Integrated care pathways for airway diseases (AIRWAYS-ICPs).
European Innovation Partnership on Active and Healthy Ageing, Action Plan B3, Mechanisms of the Development of Allergy, WP 10, Global Alliance against Chronic Respiratory Diseases, Bousquet J, Addis A, Adcock I, Agache I, Agusti A, Alonso A, Annesi-Maesano I, Anto JM, Bachert C, Baena-Cagnani CE, Bai C, Baigenzhin A, Barbara C, Barnes PJ, Bateman ED, Beck L, Bedbrook A, Bel EH, Benezet O, Bennoor KS, Benson M, Bernabeu-Wittel M, Bewick M, Bindslev-Jensen C, Blain H, Blasi F, Bonini M, Bonini S, Boulet LP, Bourdin A, Bourret R, Bousquet PJ, Brightling CE, Briggs A, Brozek J, Buhl R, Bush A, Caimmi D, Calderon M, Calverley P, Camargos PA, Camuzat T, Canonica GW, Carlsen KH, Casale TB, Cazzola M, Cepeda Sarabia AM, Cesario A, Chen YZ, Chkhartishvili E, Chavannes NH, Chiron R, Chuchalin A, Chung KF, Cox L, Crooks G, Crooks MG, Cruz AA, Custovic A, Dahl R, Dahlen SE, De Blay F, Dedeu T, Deleanu D, Demoly P, Devillier P, Didier A, Dinh-Xuan AT, Djukanovic R, Dokic D, Douagui H, Dubakiene R, Eglin S, Elliot F, Emuzyte R, Fabbri L, Fink Wagner A, Fletcher M, Fokkens WJ, Fonseca J, Franco A, Frith P, Furber A, Gaga M, Garcés J, Garcia-Aymerich J, Gamkrelidze A, Gonzales-Diaz S, Gouzi F, Guzmán MA, Haahtela T, Harrison D, Hayot M, Heaney LG, Heinrich J, Hellings PW, Hooper J, Humbert M, Hyland M, Iaccarino G, Jakovenko D, Jardim JR, Jeandel C, Jenkins C, Johnston SL, Jonquet O, Joos G, Jung KS, Kalayci O, Karunanithi S, Keil T, Khaltaev N, Kolek V, Kowalski ML, Kull I, Kuna P, Kvedariene V, Le LT, Lodrup Carlsen KC, Louis R, MacNee W, Mair A, Majer I, Manning P, de Manuel Keenoy E, Masjedi MR, Melen E, Melo-Gomes E, Menzies-Gow A, Mercier G, Mercier J, Michel JP, Miculinic N, Mihaltan F, Milenkovic B, Molimard M, Momas I, Montilla-Santana A, Morais-Almeida M, Morgan M, N'Diaye M, Nafti S, Nekam K, Neou A, Nicod L, O'Hehir R, Ohta K, Paggiaro P, Palkonen S, Palmer S, Papadopoulos NG, Papi A, Passalacqua G, Pavord I, Pigearias B, Plavec D, Postma DS, Price D, Rabe KF, Radier Pontal F, Redon J, Rennard S, Roberts J, Robine JM, Roca J, Roche N, Rodenas F, Roggeri A, Rolland C, Rosado-Pinto J, Ryan D, Samolinski B, Sanchez-Borges M, Schünemann HJ, Sheikh A, Shields M, Siafakas N, Sibille Y, Similowski T, Small I, Sola-Morales O, Sooronbaev T, Stelmach R, Sterk PJ, Stiris T, Sud P, Tellier V, To T, Todo-Bom A, Triggiani M, Valenta R, Valero AL, Valiulis A, Valovirta E, Van Ganse E, Vandenplas O, Vasankari T, Vestbo J, Vezzani G, Viegi G, Visier L, Vogelmeier C, Vontetsianos T, Wagstaff R, Wahn U, Wallaert B, Whalley B, Wickman M, Williams DM, Wilson N, Yawn BP, Yiallouros PK, Yorgancioglu A, Yusuf OM, Zar HJ, Zhong N, Zidarn M, Zuberbier T
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology. 2014 Aug. 304-23. FI: 7.125
Association of global DNA methylation and global DNA hydroxymethylation with metals and other exposures in human blood DNA samples.
Tellez-Plaza M, Tang WY, Shang Y, Umans JG, Francesconi KA, Goessler W, Ledesma M, Leon M, Laclaustra M, Pollak J, Guallar E, Cole SA, Fallin MD, Navas-Acien A
Environmental health perspectives. 2014 Sep. 946-54. FI: 7.977
Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence.
Zanchetti A, Liu L, Mancia G, Parati G, Grassi G, Stramba-Badiale M, Silani V, Bilo G, Corrao G, Zambon A, Scotti L, Zhang X, Wang H, Zhang Y, Zhang X, Guan TR, Berge E, Redon J, Narkiewicz K, Dominiczak A, Nilsson P, Viigimaa M, Laurent S, Agabiti-Rosei E, Wu Z, Zhu D, Rodicio JL, Ruilope LM, Martell-Claros N, Pinto F, Schmieder RE, Burnier M, Banach M, Cifkova R, Farsang C, Konradi A, Lazareva I, Sirenko Y, Dorobantu M, Postadzhiyan A, Accetto R, Jelakovic B, Lovic D, Manolis AJ, Stylianou P, Erdine S, Dicker D, Wei G, Xu C, Xie H, Coca A, O'Brien J, Ford G
Journal of hypertension. 2014 Sep. 1741-50. FI: 4.222
Ambulatory blood pressure monitoring is ready to replace clinic blood pressure in the diagnosis of hypertension: con side of the argument.
Redon J, Lurbe E
Hypertension. 2014 Dec. 1169-74. FI: 7.632
Prognostic value of microalbuminuria during antihypertensive treatment in essential hypertension.
Pascual JM, Rodilla E, Costa JA, Garcia-Escrich M, Gonzalez C, Redon J
Hypertension. 2014 Dec. 1228-34. FI: 7.632
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment.
Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration
The lancet. Diabetes & endocrinology. 2014 Aug. 634-47
Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients. A retrospective multicenter study.
Nieto JA, Cámara T, Camacho I, MEDITROM Investigators
European journal of internal medicine. 2014 Oct. 717-23. FI: 2.3
Telaprevir or boceprevir in HIV/HCV-1 co-infected patients in a real-life setting. Interim analysis (24 weeks). COINFECOVA-SEICV study.
Minguez C, Ortega E, Flores J, Carmena J, Masiá M, Montero M, Reus S, Tornero C, Galindo MJ, Garcia-Deltoro M, Amador C, Cuadrado JM, Usó J, López-Aldeguer J
Journal of the International AIDS Society. 2014. 19634. FI: 4.207
Executive summary of the consensus document on the management of renal disease in HIV-infected patients.
Panel of experts from the AIDS Working Group (GESIDA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Nephrology (S.E.N.), and the Spanish Society of Clinical Chemistry and Molecular Pathology (SEQC), Górriz JL, Gutiérrez F, Trullas JC, Arazo P, Arribas JR, Barril G, Cervero M, Cofan F, Domingo P, Estrada V, Fulladosa X, Galindo MJ, Gracia S, Iribarren JA, Knobel H, Lopez-Aldeguer J, Lozano F, Martínez-Castelao A, Martinez E, Mazuecos MA, Miralles C, Montañes R, Negredo E, Palacios R, Pérez-Elías MJ, Portilla J, Praga M, Quereda C, Rivero A, Santamaria JM, Sanz J, Sanz J, Miró JM
Nefrología : publicación oficial de la Sociedad Española Nefrologia. 2014 Nov 17. 768-788. FI: 1.442
Consensus document on the management of renal disease in HIV-infected patients.
Panel of experts from the AIDS Working Group (GESIDA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Nephrology (S.E.N.), and the Spanish Society of Clinical Chemistry and Molecular Pathology (SEQC), Górriz JL, Gutiérrez F, Trullas JC, Arazo P, Arribas JR, Barril G, Cervero M, Cofan F, Domingo P, Estrada V, Fulladosa X, Galindo MJ, Gracia S, Iribarren JA, Knobel H, López-Aldeguer J, Lozano F, Martínez-Castelao A, Martínez E, Mazuecos MA, Miralles C, Montañés R, Negredo E, Palacios R, Pérez-Elías MJ, Portilla J, Praga M, Quereda C, Rivero A, Santamaría JM, Sanz J, Sanz J, Miró JM
Nefrología : publicación oficial de la Sociedad Española Nefrologia. 2014 Sep 18. 29587. FI: 1.442
Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2014).
Expert Panel of GeSIDA and the National Aids Plan, Berenguer J, Polo R, Lozano F, López Aldeguer J, Antela A, Arribas JR, Asensi V, Blanco JR, Clotet B, Domingo P, Galindo MJ, Gatell JM, González-García J, Iribarren JA, Locutura J, López JC, Mallolas J, Martínez E, Miralles C, Miró JM, Moreno S, Palacios R, Pérez Elías MJ, Pineda JA, Podzamczer D, Portilla J, Pulido F, Ribera E, Riera M, Rubio R, Santos J, Sanz J, Tuset M, Vidal F, Rivero A
Enfermedades infecciosas y microbiología clínica. 2014 Aug-Sep. 447-58. FI: 1.881
Plasma selenium levels and oxidative stress biomarkers: A gene-environment interaction population-based study.
Galan-Chilet I, Tellez-Plaza M, Guallar E, De Marco G, Lopez-Izquierdo R, Gonzalez-Manzano I, Carmen Tormos M, Martin-Nuñez GM, Rojo-Martinez G, Saez GT, Martín-Escudero JC, Redon J, Javier Chaves F
Free radical biology & medicine. 2014 Sep. 229-36. FI: 5.736
Should we look for silent pulmonary embolism in patients with deep venous thrombosis?
García-Fuster MJ, Fabia MJ, Furió E, Pichler G, Redon J, Forner MJ, Martínez F
BMC cardiovascular disorders. 2014 Dec 8. 178. FI: 1.878
Executive summary of the consensus statement on assistance to women with HIV infection in the health care sector. National AIDS Plan (PNS) and AIDS Study Group (GeSIDA).
National AIDS Plan (PNS), AIDS Study Group (GeSIDA)
Enfermedades infecciosas y microbiologia clinica. 2014 Feb. 100-5. FI: 1.881
Mission possible: RNA interference rescues the hERG current.
Zarzoso M, Noujaim SF
Heart rhythm : the official journal of the Heart Rhythm Society. 2013 Jan. 137-8. FI: 5.045
Role of dihydropyridinic calcium channel blockers in the management of hypertension.
Coca A, Mazón P, Aranda P, Redón J, Divisón JA, Martínez J, Calvo C, Galcerán JM, Barrios V, Coll AR
Expert review of cardiovascular therapy. 2013 Jan. 91-105
Innovation in Cardiology: Introduction.
Avanzas P, Bayes-Genis A, Pérez de Isla L, Sanchis J, Heras M
Revista española de cardiología. 2013 Feb. 133. FI: 3.204
Ambulatory blood pressure monitoring in children and adolescents: coming of age?
Lurbe E, Torró MI, Alvarez J
Current hypertension reports. 2013 Jun. 143-9. FI: 3.744
Gender differences related to the presence of atrial fibrillation in older hypertensive patients.
Fácila L, Pallarés V, Morillas P, Cordero A, Llisterri JL, Sánchis C, Gorriz JL, Castillo J, Gil V, Redon J
World journal of cardiology. 2013 May 26. 124-31
Morning and smooth 24-h ambulatory blood pressure control is not achieved in general practice: results from the SURGE observational study.
Parati G, Bilo G, Redon J, SURGE Steering Committee
Journal of hypertension. 2013 Mar. 616-23; discussion 623. FI: 3.806
Clinical inertia in poorly controlled elderly hypertensive patients: a cross-sectional study in spanish physicians to ascertain reasons for not intensifying treatment.
Gil-Guillén V, Orozco-Beltrán D, Carratalá-Munuera C, Márquez-Contreras E, Durazo-Arvizu R, Cooper R, Pertusa-Martínez S, Pita-Fernandez S, González-Segura D, Martin-de-Pablo JL, Pallarés V, Fernández A, Redón J
American journal of cardiovascular drugs : drugs, devices, and other interventions. 2013 Jun. 213-9. FI: 2.069
The global cardiovascular risk transition: associations of four metabolic risk factors with national income, urbanization, and Western diet in 1980 and 2008.
Danaei G, Singh GM, Paciorek CJ, Lin JK, Cowan MJ, Finucane MM, Farzadfar F, Stevens GA, Riley LM, Lu Y, Rao M, Ezzati M, Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group
Circulation. 2013 Apr 9. 1493-502, 1502e1-8. FI: 15.202
Increased pulse pressure is associated with left atrial enlargement in resistant hypertensive patients.
Armario P, Oliveras A, Hernández-Del-Rey R, Suárez C, Martell N, Ruilope LM, De La Sierra A, Investigators of Resistant Hypertension Registry of the Spanish Society of Hypertension
Blood pressure. 2013 Feb. 39-44. FI: 1.391
An evaluation of the impact of technical bias on the concordance rate between primary and recurrent tumors in breast cancer.
Pérez-Fidalgo JA, Eroles P, Ferrer J, Bosch A, Burgués O, Martínez F, Bermejo B, Lluch A, González-Angulo AM
Breast (Edinburgh, Scotland). 2013 Oct. 974-9. FI: 2.581
Childhood blood pressure: trends and future tracks.
Lurbe E
Hypertension. 2013 Aug. 242-3. FI: 6.873
Sexual dimorphism in the transition from masked to sustained hypertension in healthy youths.
Lurbe E, Thijs L, Torro MI, Alvarez J, Staessen JA, Redon J
Hypertension. 2013 Aug. 410-4. FI: 6.873
Regression of left ventricular hypertrophy and microalbuminuria changes during antihypertensive treatment.
Rodilla E, Pascual JM, Costa JA, Martin J, Gonzalez C, Redon J
Journal of hypertension. 2013 Aug. 1683-91. FI: 3.806
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F, Task Force Members
Journal of hypertension. 2013 Jul. 1281-357. FI: 3.806
2013 ESH/ESC Guidelines for the Management of Arterial Hypertension.
Task Force for the management of arterial hypertension of the European Society of Hypertension, Task Force for the management of arterial hypertension of the European Society of Cardiology
Blood pressure. 2013 Aug. 193-278. FI: 1.391
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F, Redon J, Dominiczak A, Narkiewicz K, Nilsson PM, Burnier M, Viigimaa M, Ambrosioni E, Caufield M, Coca A, Olsen MH, Schmieder RE, Tsioufis C, van de Borne P, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Clement DL, Coca A, Gillebert TC, Tendera M, Rosei EA, Ambrosioni E, Anker SD, Bauersachs J, Hitij JB, Caulfield M, De Buyzere M, De Geest S, Derumeaux GA, Erdine S, Farsang C, Funck-Brentano C, Gerc V, Germano G, Gielen S, Haller H, Hoes AW, Jordan J, Kahan T, Komajda M, Lovic D, Mahrholdt H, Olsen MH, Ostergren J, Parati G, Perk J, Polonia J, Popescu BA, Reiner Z, Rydén L, Sirenko Y, Stanton A, Struijker-Boudier H, Tsioufis C, van de Borne P, Vlachopoulos C, Volpe M, Wood DA
European heart journal. 2013 Jul. 2159-219. FI: 14.097
Updated ESH position paper on interventional therapy of resistant hypertension.
Schmieder RE, Redon J, Grassi G, Kjeldsen SE, Mancia G, Narkiewicz K, Parati G, Ruilope L, van de Borne P, Tsioufis C
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2013 May. R58-66. FI: 3.173
Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study.
Cahn P, Pozniak AL, Mingrone H, Shuldyakov A, Brites C, Andrade-Villanueva JF, Richmond G, Buendia CB, Fourie J, Ramgopal M, Hagins D, Felizarta F, Madruga J, Reuter T, Newman T, Small CB, Lombaard J, Grinsztejn B, Dorey D, Underwood M, Griffith S, Min S, extended SAILING Study Team
Lancet. 2013 Aug 24. 700-8. FI: 39.06
EURECCA colorectal: multidisciplinary mission statement on better care for patients with colon and rectal cancer in Europe.
van de Velde CJ, Aristei C, Boelens PG, Beets-Tan RG, Blomqvist L, Borras JM, van den Broek CB, Brown G, Coebergh JW, Cutsem EV, Espin E, Gore-Booth J, Glimelius B, Haustermans K, Henning G, Iversen LH, Han van Krieken J, Marijnen CA, Mroczkowski P, Nagtegaal I, Naredi P, Ortiz H, Påhlman L, Quirke P, Rödel C, Roth A, Rutten HJ, Schmoll HJ, Smith J, Tanis PJ, Taylor C, Wibe A, Gambacorta MA, Meldolesi E, Wiggers T, Cervantes A, Valentini V, European Registration of Cancer Care
European journal of cancer (Oxford, England : 1990). 2013 Sep. 2784-90. FI: 5.061
Unpredicted ovulations and conceptions during early pregnancy: an explanatory mechanism of human superfetation.
Tarín JJ, García-Pérez MA, Hermenegildo C, Cano A
Reproduction, fertility, and development. 2013. 1012-9. FI: 2.583
Medium-term results of cryoballoon ablation of the pulmonary veins in patients with paroxysmal and persistent atrial fibrillation. First experience of a Spanish center.
Ferrero-de Loma-Osorio A, Izquierdo-de Francisco M, Martínez-Brotons A, Sánchez-Gómez JM, Mascarell-Gregori B, Ruiz-Ros V, Cuenca-Romero I, García-Civera R, Chorro-Gascó FJ, Ruiz-Granell R
Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing. 2013 Aug. 189-96. FI: 1.386
Epidemiology and prevention of cardiovascular disease in Revista Española de Cardiología.
Heras M, Pérez de Isla L, Sanchis J
Revista clínica española. 2013 Oct. 361-362. FI: 2.008
European society of hypertension position paper on ambulatory blood pressure monitoring.
O'Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, Clement D, de la Sierra A, de Leeuw P, Dolan E, Fagard R, Graves J, Head GA, Imai Y, Kario K, Lurbe E, Mallion JM, Mancia G, Mengden T, Myers M, Ogedegbe G, Ohkubo T, Omboni S, Palatini P, Redon J, Ruilope LM, Shennan A, Staessen JA, Vanmontfrans G, Verdecchia P, Waeber B, Wang J, Zanchetti A, Zhang Y, European Society of Hypertension Working Group on Blood Pressure Monitoring
Journal of hypertension. 2013 Sep. 1731-68. FI: 3.806
Update on ischemic heart disease and critical care cardiology.
Jiménez-Candil J, Díaz-Castro O, Barrabés JA, García de la Villa B, Bodí Peris V, López Palop R, Fernández-Ortiz A, Martínez-Sellés M
Revista española de cardiología. 2013 Mar. 198-204. FI: 3.204
Ambulatory blood pressure in children: confidence and wisdom.
Lurbe E
Journal of hypertension. 2013 Nov. 2125-7. FI: 3.806
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I, SAVOR-TIMI 53 Steering Committee and Investigators
The New England journal of medicine. 2013 Oct 3. 1317-26. FI: 51.658
Smoking, Menthol Cigarettes and All-Cause, Cancer and Cardiovascular Mortality: Evidence from the National Health and Nutrition Examination Survey (NHANES) and a Meta-Analysis.
Jones MR, Tellez-Plaza M, Navas-Acien A
PloS one. 2013 Oct 25. e77941. FI: 3.534
Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus.
Dunkler D, Dehghan M, Teo KK, Heinze G, Gao P, Kohl M, Clase CM, Mann JF, Yusuf S, Oberbauer R, ONTARGET Investigators
JAMA internal medicine. 2013 Oct 14. 1682-92
Incidence of tuberculosis in HIV-infected patients in Spain: the impact of treatment for LTBI.
Martínez-Pino I, Sambeat MA, Lacalle-Remigio JR, Domingo P, VACH Cohort Study Group
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 2013 Dec. 1545-51. FI: 2.61
Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection.
Walmsley SL, Antela A, Clumeck N, Duiculescu D, Eberhard A, Gutiérrez F, Hocqueloux L, Maggiolo F, Sandkovsky U, Granier C, Pappa K, Wynne B, Min S, Nichols G, SINGLE Investigators
The New England journal of medicine. 2013 Nov 7. 1807-18. FI: 51.658
Cadmium exposure and incident peripheral arterial disease.
Tellez-Plaza M, Guallar E, Fabsitz RR, Howard BV, Umans JG, Francesconi KA, Goessler W, Devereux RB, Navas-Acien A
Circulation. Cardiovascular quality and outcomes. 2013 Nov. 626-33
Allergic contact dermatitis to benzocaine: the importance of concomitant positive patch test results.
González-Rodríguez AJ, Gutiérrez-Paredes EM, Revert Fernández Á, Jordá-Cuevas E
Actas dermo-sifiliográficas. 2013 Mar. 156-8
Cadmium exposure and clinical cardiovascular disease: a systematic review.
Tellez-Plaza M, Jones MR, Dominguez-Lucas A, Guallar E, Navas-Acien A
Current atherosclerosis reports. 2013 Oct. 356. FI: 3.059
Cadmium and cardiovascular risk.
Tellez-Plaza M, Guallar E, Howard BV, Navas-Acien A
Epidemiology (Cambridge, Mass.). 2013 Sep. 784-5. FI: 6.178
Cadmium exposure and incident cardiovascular disease.
Tellez-Plaza M, Guallar E, Howard BV, Umans JG, Francesconi KA, Goessler W, Silbergeld EK, Devereux RB, Navas-Acien A
Epidemiology (Cambridge, Mass.). 2013 May. 421-9. FI: 6.178
Urine arsenic and prevalent albuminuria: evidence from a population-based study.
Zheng LY, Umans JG, Tellez-Plaza M, Yeh F, Francesconi KA, Goessler W, Silbergeld EK, Guallar E, Howard BV, Weaver VM, Navas-Acien A
American journal of kidney diseases : the official journal of the National Kidney Foundation. 2013 Mar. 385-94. FI: 5.756
Heritability and preliminary genome-wide linkage analysis of arsenic metabolites in urine.
Tellez-Plaza M, Gribble MO, Voruganti VS, Francesconi KA, Goessler W, Umans JG, Silbergeld EK, Guallar E, Franceschini N, North KE, Kao WH, MacCluer JW, Cole SA, Navas-Acien A
Environmental health perspectives. 2013 Mar. 345-51. FI: 7.029
Menthol cigarettes, race/ethnicity, and biomarkers of tobacco use in U.S. adults: the 1999-2010 National Health and Nutrition Examination Survey (NHANES).
Jones MR, Apelberg BJ, Tellez-Plaza M, Samet JM, Navas-Acien A
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2013 Feb. 224-32. FI: 4.324
Impact of obesity-related genes in Spanish population
Martínez-García F, Mansego ML, Rojo-Martínez G, De Marco-Solar G, Morcillo S, Soriguer F, Redón J, Pineda Alonso M, Martín-Escudero JC, Cooper RS, Chaves FJ.
BMC genetics. 2013 Nov 23. 111. FI: 2.266
Subclinical hypothyroidism, aspects that still have to be clarified.
Hernández Mijares A
Revista clínica española. 2013 Nov. 385-7. FI: 2.008
Achievement of low-density lipoprotein cholesterol therapeutic goal in lipid and vascular risk units of the Spanish Arteriosclerosis Society.
Pedro-Botet J, Mostaza JM, Pintó X, Banegas JR, En Nombre del Grupo de Investigadores EDICONDIS-ULISEA
. 2013 Sep-Oct. 155-63
Anales de Pediatría: a new phase.
Lurbe I Ferrer E, Alsina Manrique de Lara L, Rodríguez Fernández LM, Solís Sánchez G
Anales de pediatría (Barcelona, Spain : 2003). 2013 Nov. 275-6. FI: 0.867
Safety and Efficacy of Low Blood Pressures Among Patients With Diabetes Subgroup Analyses From the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial).
Redon J, Mancia G, Sleight P, Schumacher H, Gao P, Pogue J, Fagard R, Verdecchia P, Weber M, Böhm M, Williams B, Yusoff K, Teo K, Yusuf S, ONTARGET Investigators
Journal of the American College of Cardiology. 2012 Jan 3. 74-83. FI: 14.086
Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group 'Hypertension Arrhythmias and Thrombosis' of the European Society of Hypertension.
Manolis AJ, Rosei EA, Coca A, Cifkova R, Erdine SE, Kjeldsen S, Lip GY, Narkiewicz K, Parati G, Redon J, Schmieder R, Tsioufis C, Mancia G
Journal of hypertension. 2012 Feb. 239-252. FI: 3.806
Association of central and peripheral pulse pressure with intermediate cardiovascular phenoytpes.
Neisius U, Bilo G, Taurino C, McClure JD, Schneider MP, Kawecka-Jaszcz K, Stolarz-Skrzypek K, Klima L, Staessen JA, Kuznetsova T, Redon J, Martinez F, Rosei EA, Muiesan ML, Melander O, Zannad F, Rossignol P, Laurent S, Collin C, Lonati L, Zanchetti A, Dominiczak AF, Delles C
Journal of hypertension. 2012 Jan. 67-74. FI: 3.806
Blood pressure and obesity exert independent influences on pulse wave velocity in youth.
Lurbe E, Torro I, Garcia-Vicent C, Alvarez J, Fernández-Fornoso JA, Redon J
Hypertension. 2012 Aug. 550-5. FI: 6.873
ESH position paper: renal denervation - an interventional therapy of resistant hypertension.
Schmieder RE, Redon J, Grassi G, Kjeldsen SE, Mancia G, Narkiewicz K, Parati G, Ruilope L, van de Borne P, Tsioufis C
Journal of hypertension. 2012 May. 837-41. FI: 3.806
Mutations in the protease gene associated with virological failure to lopinavir/ritonavir-containing regimens.
Santos JR, Llibre JM, Imaz A, Domingo P, Iribarren JA, Mariño A, Miralles C, Galindo MJ, Ornelas A, Moreno S, Schapiro JM, Clotet B, Call Conference Group
The Journal of antimicrobial chemotherapy. 2012 Jun. 1462-9. FI: 5.338
Sustained Virological Response to Interferon Plus Ribavirin Reduces Non-Liver-Related Mortality in Patients Coinfected With HIV and Hepatitis C Virus.
Berenguer J, Rodríguez E, Miralles P, Von Wichmann MA, López-Aldeguer J, Mallolas J, Galindo MJ, Van Den Eynde E, Téllez MJ, Quereda C, Jou A, Sanz J, Barros C, Santos I, Pulido F, Guardiola JM, Ortega E, Rubio R, Jusdado JJ, Montes ML, Gaspar G, Esteban H, Bellón JM, González-García J, the GESIDA HIV/HCV Cohort Study Group
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2012 Sep. 728-736. FI: 9.374000000000001
Plasma raltegravir exposure influences the antiviral activity and selection of resistance mutations.
Garrido C, de Mendoza C, Alvarez E, García F, Morello J, Garcia S, Ribera E, Rodríguez-Novoa S, Gutierrez F, Soriano V, Sinres Team
AIDS research and human retroviruses. 2012 Feb. 156-64. FI: 2.705
Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy.
Betancor G, Garriga C, Puertas MC, Nevot M, Anta L, Blanco JL, Pérez-Elías MJ, de Mendoza C, Martínez MA, Martinez-Picado J, Menéndez-Arias L, Resistance Platform of the Spanish AIDS Research Network (ResRIS), Iribarren JA, Caballero E, Ribera E, Llibre JM, Clotet B, Jaén A, Dalmau D, Gatel JM, Peraire J, Vidal F, Vidal C, Riera M, Córdoba J, López Aldeguer J, Galindo MJ, Gutiérrez F, Álvarez M, García F, Pérez-Romero P, Viciana P, Leal M, Palomares JC, Pineda JA, Viciana I, Santos J, Rodríguez P, Gómez Sirvent JL, Gutiérrez C, Moreno S, Pérez-Olmeda M, Alcamí J, Rodríguez C, del Romero J, Cañizares A, Pedreira J, Miralles C, Ocampo A, Morano L, Aguilera A, Garrido C, Manuzza G, Poveda E, Soriano V
Retrovirology. 2012 Aug 13. 68. FI: 5.657
Home blood pressure control is low during the critical morning hours in patients with hypertension: the SURGE observational study.
Redon J, Bilo G, Parati G, SURGE Steering Committee
Family practice. 2012 Aug. 421-6. FI: 1.828
Impaired exercise tolerance is associated with increased urine albumin excretion in the early stages of essential hypertension.
Tsiachris D, Tsioufis C, Syrseloudis D, Thomopoulos C, Mpafakis I, Michaelides A, Redon J, Stefanadis C
European journal of preventive cardiology. 2012 Jun. 452-9
Comment on ESH position paper: renal denervation - an interventional therapy of resistant hypertension.
Schmieder RE, Redon J
Journal of hypertension. 2012 Dec. 2443. FI: 3.806
Ambulatory Blood Pressure Values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET).
Mancia G, Parati G, Bilo G, Gao P, Fagard R, Redon J, Czuriga I, Polák M, Ribeiro JM, Sanchez R, Trimarco B, Verdecchia P, van Mieghem W, Teo K, Sleight P, Yusuf S
Hypertension. 2012 Dec. 1400-6. FI: 6.873
Necessity of add-on therapy in the treatment of hypertension: a new marker of high cardiovascular risk?
Redon J
Journal of hypertension. 2012 Nov. 2085-7. FI: 3.806
Microalbuminuria as surrogate endpoint in therapeutic trials.
Redon J, Martinez F
Current hypertension reports. 2012 Aug. 345-9. FI: 3.744
Cardiorenal end points in a trial of aliskiren for type 2 diabetes.
Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Persson F, Desai AS, Nicolaides M, Richard A, Xiang Z, Brunel P, Pfeffer MA, ALTITUDE Investigators
The New England journal of medicine. 2012 Dec 6. 2204-13. FI: 51.658
Polymorphisms of the UCP2 gene are associated with body fat distribution and risk of abdominal obesity in Spanish population.
Martinez-Hervas S, Mansego ML, de Marco G, Martinez F, Alonso MP, Morcillo S, Rojo-Martinez G, Real JT, Ascaso JF, Redon J, Martin Escudero JC, Soriguer F, Chaves FJ
European journal of clinical investigation. 2012 Feb. 171-178. FI: 3.365
Common variants of the liver fatty acid binding protein gene influence the risk of type 2 diabetes and insulin resistance in Spanish population.
Mansego ML, Martínez F, Martínez-Larrad MT, Zabena C, Rojo G, Morcillo S, Soriguer F, Martín-Escudero JC, Serrano-Ríos M, Redon J, Chaves FJ
PloS one. 2012. e31853. FI: 3.73
National, regional, and global trends in adult overweight and obesity prevalences.
Stevens GA, Singh GM, Lu Y, Danaei G, Lin JK, Finucane MM, Bahalim AN, McIntire RK, Gutierrez HR, Cowan M, Paciorek CJ, Farzadfar F, Riley L, Ezzati M, Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Body Mass Index)
Population health metrics. 2012 Nov 20. 22
Budget impact analysis of antiretroviral therapy. A reflection based on the GESIDA guidelines.
Grupo de trabajo de la Cohorte VACH
Gaceta sanitaria / S.E.S.P.A.S. 2012 Nov-Dec. 541-6. FI: 1.116

API-ecosystem for cross-sectorial exchange of 3D personal data

Referencia:
BodyPass
Investigador/a principal:
Josep Redón i Mas
Entidad financiadora:
European Commission (H2020)
Duración:
01/01/2018 - 01/01/2021
Presupuesto total:
€351.938

Big Data for Medical Analytics

Referencia:
BigMedilytics
Investigador/a principal:
Josep Redón i Mas
Entidad financiadora:
European Commission (H2020)
Duración:
01/01/2018 - 01/01/2021
Presupuesto total:
€1.062.136

Estudio experimental in vivo e in vitro y la aplicación clínica del impacto de las proteínas del complejo Rhabphilin-Rab en el desarrollo del daño renal y cardiovascular

Referencia:
PI16/01402
Entidad financiadora:
Instituto de Salud Carlos III
Duración:
01/01/2017 - 31/12/2019
Presupuesto total:
€194.205

"BigData Heart" Big Data 4 Better Hearts

Referencia:
IMI2-2015-07-07
Investigador/a principal:
Josep Redón i Mas
Entidad financiadora:
European Society of Cardiology
Duración:
01/03/2017 - 01/03/2010
Presupuesto total:
€386.250

Metales y arteriosclerosis subclínica: papel de la variación genética y epigenética en genes candidatos.

Referencia:
PI15/00071
Investigador/a principal:
María Téllez Plaza
Entidad financiadora:
Instituto de Salud Carlos III
Duración:
01/01/2016 - 31/12/2018
Presupuesto total:
€195.415

Análisis de datos avanzado como ayuda a la decisión en clínica

Referencia:
VLC-BIOCLINIC Subprograma A
Investigador/a principal:
María Téllez Plaza
Entidad financiadora:
Fundación Investigación Hospital Clínico Universitario de Valencia
Duración:
01/01/2016 - 31/12/2017
Presupuesto total:
€4.000

Sistema basado en datos como ayuda a la decisión clínica.

Referencia:
VLC-BIOCLINIC SIMBAD
Investigador/a principal:
María Téllez Plaza
Entidad financiadora:
Fundación Investigación Hospital Clínico Universitario de Valencia
Duración:
01/01/2015 - 31/12/2015
Presupuesto total:
€4.000

Cohorte de GESIDA de pacientes coinfectados por VIH y VHC que reciben tratamiento para la hepatitis C.

Referencia:
FIPSE 36443/03
Investigador/a principal:
Josep Redón i Mas
Entidad financiadora:
FIPSE (Fundación para la Investigación y la prevención de SIDA en España)
Duración:
30/12/2015 - 30/12/2015

Innovation Platform

Referencia:
PT13/0006/0023
Investigador/a principal:
Josep Redón i Mas
Entidad financiadora:
Instituto de Salud Carlos III
Duración:
01/01/2014 - 31/12/2017
Presupuesto total:
€38.985

Biobank Platform

Referencia:
PT13/0010/0004
Investigador/a principal:
Josep Redón i Mas
Entidad financiadora:
Instituto de Salud Carlos III
Duración:
01/01/2014 - 31/12/2017
Presupuesto total:
€46.500

Podocitos y sus componentes como biomarcadores de lesion en hipertensión arterial, diabetes y obesidad

Referencia:
ACOMP/2014/116
Investigador/a principal:
Josep Redón i Mas
Entidad financiadora:
Conselleria de Educación, Cultura y Deporte
Duración:
01/01/2014 - 31/12/2014
Presupuesto total:
€10.600

DNA Methylation and Hydroxymethylation, Metal Exposure and Cardiovascular Risk: an Epidemiologic Study.

Referencia:
CP12/03080
Investigador/a principal:
María Téllez Plaza
Entidad financiadora:
Instituto de Salud Carlos III
Duración:
01/01/2013 - 01/01/2015
Presupuesto total:
€60.750

Estudio de la efectividad a largo plazo del tratamiento de la hepatitis crónica C en pacientes coinfectados por VIH y VHC

Referencia:
EC07/90725
Entidad financiadora:
Instituto de Salud Carlos III
Duración:
04/10/2013 - 04/10/2013

Determinantes genéticos para el desarrollo de microalbuminuria en la hipertensión arterial esencial

Referencia:
GE-029/11
Investigador/a principal:
Fernando Martínez García
Entidad financiadora:
Generalitat Valenciana. Conselleria de Sanitat
Duración:
22/10/2012 - 22/10/2012
Presupuesto total:
€6.000

EU-MASCARA Markers for Sub-Clinical Cardiovascular Risk Assessment.

Referencia:
HEALTH 2011.2.4.2-2
Investigador/a principal:
Josep Redón i Mas
Entidad financiadora:
European Commission
Duración:
01/01/2011 - 31/12/2015
Presupuesto total:
€374.920

Epigenetics: Bench to Bedside.

Referencia:
COST Action TD0905
Entidad financiadora:
European Commission
Duración:
13/05/2010 - 13/05/2016

Interaction of genetic and adquired factors on the risk to develop microalbuminuria in essential hypertension: a genomic and metabolomic approach.

Referencia:
PS09/00201
Investigador/a principal:
Josep Redón i Mas
Entidad financiadora:
Instituto de Salud Carlos III
Duración:
01/01/2010 - 31/12/2012
Presupuesto total:
€180.000

Big Data for Better Hearts

Referencia:
BigData@Heart
Investigador/a principal:
Josep Redón i Mas
Entidad financiadora:
European Commission (IMI)
Duración:
09/07/1905 - 14/07/1905
Presupuesto total:
€386.250

Epigenetic Chemical Biology (EPICHEM)

Referencia:
COST Action CM1406
Investigador/a principal:
María Téllez Plaza
Entidad financiadora:
European Commission
Duración:
07/07/1905 - 11/07/1905

Seis investigadores de INCLIVA obtienen plaza en el cuerpo de catedráticos de la Universidad de Valencia

Cuatro de ellos son médicos del Hospital Clínico Universitario de Valencia

Publicado el 03/08/2018.Leer más »

Por segundo año, INCLIVA y el Hospital Clínico participan en la campaña mundial sobre detección de hipertensos “Mayo mes de la medición”

iNCLIVA y el Hospital Clínico participan en la campaña mundial Mayo Measurement Month (MMM) 

Publicado el 11/05/2018.Leer más »

INCLIVA participa en un proyecto europeo de big data para mejorar la asistencia sanitaria

El proyecto BigMedilytics busca mejorar los resultados del paciente y reducir los costes sanitarios mediante la aplicación de tecnologías de Inteligencia Artificial en el ámbito de la salud.

Publicado el 14/04/2018.Leer más »

Reducir la exposición al plomo y al cadmio explica el 30% de la disminución en la mortalidad por causas cardiovasculares

La investigación se ha realizado con la colaboración de la Universidad John Hopkins y  del Centro Nacional de Epidemiología.

Publicado el 17/01/2018.Leer más »

El investigador Dr. Josep Redón, Premio Valencianos en la Onda en la categoría de Ciencia

Los premios reconocen la labor de instituciones y personalidades valencianas en diferentes ámbitos.

Publicado el 17/11/2017.Leer más »

La Dra. María Téllez recibe el Premio Jóvenes Investigadores de la Fundación AstraZeneca

Téllez ha recibido el premio en la categoría de Síndrome Coronario Agudo.

Publicado el 20/09/2017.Leer más »

INCLIVA y el Hospital Clínico se sumarán en el mes de mayo a una campaña mundial sobre detección de hipertensos

El Incliva y el Servicio de Medicina Interna colaboran con la campaña Mayo Measurement Month (MMM) es una iniciativa para la detección mundial de hipertensos que tiene como objetivo concienciar sobre la importancia de la presión arterial.
 

 

Publicado el 26/04/2017.Leer más »

Un año más, los investigadores de INCLIVA entre los mejores investigadores de Valencia

Según el ranking basado en el factor h elaborado por DIH, el Dr. Carlos Simón el segundo en el ranking de su especialidad en España.

Publicado el 11/01/2017.Leer más »

La hipertensión es la causa de fallecimiento número uno en el mundo

Un artículo de revisión, recientemente publicado en la prestigiosa revista Lancet, identifica estrategias claves para reducir su impacto sobre la salud a nivel mundial y pretende ser el punto de partida para implementar las acciones clave identificadas. En el proyecto participa el investigador valenciano Fernando Martínez, médico adjunto de Medicina Interna del Hospital Clínico.

Publicado el 10/11/2016.Leer más »

Investigadoras de INCLIVA demuestran que alteraciones en los podocitos predicen el daño renal en pacientes con lupus

El Lupus Eritematoso Sistémico es una enfermedad autoinmune inflamatoria crónica. Afecta a 10 casos cada 100.000 habitantes y 9 de cada 10 afectados son mujeres.

Publicado el 13/05/2016.Leer más »

La hipertensión, el factor de riesgo del síndrome metabólico con mayor impacto.

El 40% de las muertes de valencianos causadas por un evento cardiovascular se asocian a la hipertensión. El estudio se ha realizado con la colaboración de más de 900 profesionales de la Atención Primaria de la sanidad pública valenciana que participan en el Estudio Cardiometabólico Valenciano ESCARVAL.

Publicado el 28/04/2016.Leer más »